Nicotene Substitute Therapy

Nicotine Substitute Therapy plus Anxiety Disorder Medication and its effects on Smoking Cessation

The purpose of this study is to investigate if the combined effects of nicotine substitute therapy and Zoloft (anxiety disorder medication) will reduce the amount of anxiety and cravings patients experience during smoking cessation; as well as, increase the success rate of staying smoke free. There will be 200 participants in this study, consisting of 100 white females and 100 white males between the ages of 18 to 22. We’ll be using a 2x2 factorial design with a pre and post test. The pre and post test will consist of the same daily anxiety test that participants will fill out each night of the treatment. The participants will receive one of four conditions, either the nicotine transdermal 24 hour patch plus 50mg Zoloft pill; the 50mg Zoloft plus placebo nicotine patch; the Nicotine transdermal 24-hour patch plus a placebo Zoloft; or they will receive both the placebo nicotine patch and the placebo Zoloft pill. Both the nicotine transdermal patch and the 50mg Zoloft, as well as, the corresponding placebo treatments are to be administered eac

Some topics in this essay:
Participants White, Jacob Zevin, Administration FDA, Norman Prochazka, Cessation Abstract, Appendix Initial, Hunter Thompson, Rose Westman, Zyban Zoloft, Cessation Nearly, smoking cessation, et al, replacement therapy, hunter et al, hunter et, nicotine patch, transdermal patch, nicotine replacement, daily anxiety, nicotine replacement therapy, nicotine transdermal, nasal spray, nicotine transdermal patch, daily anxiety test, success rate staying,